Eris Lifesciences P/B Ratio
Eris Lifesciences (ERIS) P/B ratio is 4.81 (High), book value per share ₹2782.86 vs Healthcare average P/B of -0.01 — Very High - Significant premium, high growth expectations or speculative. Read Eris Lifesciences dividend policy for the complete payout history and dividend yield track record.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
ERIS P/B Ratio — Valuation Insights & Book Value Analysis
Eris Lifesciences price-to-book ratio interpretation, valuation status and historical context — current P/B 4.81 (High). Explore ERIS intrinsic value to estimate fundamental worth using multiple valuation models.
- Stock appears overvalued with PB of 4.81, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 774.5% above historical average
- Trading at premium to sector average PB of -0.01
Eris Lifesciences P/B Ratio Historical Trend
ERIS annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see Eris Lifesciences stock price NSE.
ERIS Historical P/B Ratio — Book Value Per Share & Year-End Price
Eris Lifesciences annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 0.47 | ₹2782.86 | ₹1321.30 | ₹3,896 | Low |
| 2025 | 0.64 | ₹2337.14 | ₹1505.60 | ₹3,272 | Low |
| 2024 | 0.6 | ₹2301.43 | ₹1373.70 | ₹3,222 | Low |
| 2023 | 0.57 | ₹1586.43 | ₹910.00 | ₹2,221 | Low |
| 2022 | 0.47 | ₹1362.86 | ₹647.25 | ₹1,908 | Low |
ERIS vs Healthcare Peers — P/B Ratio Comparison
Eris Lifesciences P/B 4.81 vs Healthcare average -0.01, median 0.62 — range -6.55–1.09.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.0 | ₹65 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.82 | ₹129 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.21 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |